Global Non Alcoholic Fatty Liver Disease Sales Market Report 2017

February 2017 | 120 pages | ID: G9944B568FAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Non Alcoholic Fatty Liver Disease

Revenue, means the sales value of Non Alcoholic Fatty Liver Disease

This report studies sales (consumption) of Non Alcoholic Fatty Liver Disease in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Conatus Pharmaceuticals
• Daewoong Pharmaceutical
• Galmed International
• Kyorin Pharmaceutical
• Metabolic Solutions Development
• Novartis AG
• Phenex Pharmaceuticals
• Raptor Pharmaceuticals
• TCM Biotech International
• Tobira Therapeutics
• Verva Pharmaceuticals
• Zafgen

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Non Alcoholic Fatty Liver Disease in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Insulin Sensitizers
• Statins
• Pentoxifylline
• Others

Split by applications, this report focuses on sales, market share and growth rate of Non Alcoholic Fatty Liver Disease in each application, can be divided into

• Pediatric?
• Adults

Contents

Global Non Alcoholic Fatty Liver Disease Sales Market Report 2017

1 NON ALCOHOLIC FATTY LIVER DISEASE OVERVIEW

1.1 Product Overview and Scope of Non Alcoholic Fatty Liver Disease
1.2 Classification of Non Alcoholic Fatty Liver Disease
  1.2.1 Insulin Sensitizers
  1.2.2 Statins
  1.2.3 Pentoxifylline
  1.2.4 Others
1.3 Application of Non Alcoholic Fatty Liver Disease
  1.3.1 Pediatric?
  1.3.2 Adults
1.4 Non Alcoholic Fatty Liver Disease Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Non Alcoholic Fatty Liver Disease (2012-2022)
  1.5.1 Global Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2022)
  1.5.2 Global Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)

2 GLOBAL NON ALCOHOLIC FATTY LIVER DISEASE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Non Alcoholic Fatty Liver Disease Market Competition by Manufacturers
  2.1.1 Global Non Alcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Non Alcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2012-2017)
2.2 Global Non Alcoholic Fatty Liver Disease (Volume and Value) by Type
  2.2.1 Global Non Alcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)
  2.2.2 Global Non Alcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
2.3 Global Non Alcoholic Fatty Liver Disease (Volume and Value) by Regions
  2.3.1 Global Non Alcoholic Fatty Liver Disease Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Non Alcoholic Fatty Liver Disease Revenue and Market Share by Regions (2012-2017)
2.4 Global Non Alcoholic Fatty Liver Disease (Volume) by Application

3 UNITED STATES NON ALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)
  3.1.1 United States Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  3.1.2 United States Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  3.1.3 United States Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
3.2 United States Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
3.3 United States Non Alcoholic Fatty Liver Disease Sales and Market Share by Type
3.4 United States Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

4 CHINA NON ALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

4.1 China Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)
  4.1.1 China Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  4.1.2 China Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  4.1.3 China Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
4.2 China Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
4.3 China Non Alcoholic Fatty Liver Disease Sales and Market Share by Type
4.4 China Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

5 EUROPE NON ALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)
  5.1.1 Europe Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  5.1.2 Europe Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
5.2 Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
5.3 Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Type
5.4 Europe Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

6 JAPAN NON ALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)
  6.1.1 Japan Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  6.1.2 Japan Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
6.2 Japan Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
6.3 Japan Non Alcoholic Fatty Liver Disease Sales and Market Share by Type
6.4 Japan Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

7 SOUTHEAST ASIA NON ALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)
  7.1.1 Southeast Asia Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
7.2 Southeast Asia Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
7.3 Southeast Asia Non Alcoholic Fatty Liver Disease Sales and Market Share by Type
7.4 Southeast Asia Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

8 INDIA NON ALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

8.1 India Non Alcoholic Fatty Liver Disease Sales and Value (2012-2017)
  8.1.1 India Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  8.1.2 India Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  8.1.3 India Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
8.2 India Non Alcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
8.3 India Non Alcoholic Fatty Liver Disease Sales and Market Share by Type
8.4 India Non Alcoholic Fatty Liver Disease Sales and Market Share by Application

9 GLOBAL NON ALCOHOLIC FATTY LIVER DISEASE MANUFACTURERS ANALYSIS

9.1 Conatus Pharmaceuticals
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.1.2.1 Insulin Sensitizers
    9.1.2.2 Statins
  9.1.3 Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Daewoong Pharmaceutical
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.2.2.1 Insulin Sensitizers
    9.2.2.2 Statins
  9.2.3 Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Galmed International
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.3.2.1 Insulin Sensitizers
    9.3.2.2 Statins
  9.3.3 Galmed International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Kyorin Pharmaceutical
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.4.2.1 Insulin Sensitizers
    9.4.2.2 Statins
  9.4.3 Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Metabolic Solutions Development
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.5.2.1 Insulin Sensitizers
    9.5.2.2 Statins
  9.5.3 Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Novartis AG
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.6.2.1 Insulin Sensitizers
    9.6.2.2 Statins
  9.6.3 Novartis AG Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Phenex Pharmaceuticals
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.7.2.1 Insulin Sensitizers
    9.7.2.2 Statins
  9.7.3 Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Raptor Pharmaceuticals
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.8.2.1 Insulin Sensitizers
    9.8.2.2 Statins
  9.8.3 Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 TCM Biotech International
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.9.2.1 Insulin Sensitizers
    9.9.2.2 Statins
  9.9.3 TCM Biotech International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Tobira Therapeutics
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
    9.10.2.1 Insulin Sensitizers
    9.10.2.2 Statins
  9.10.3 Tobira Therapeutics Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Verva Pharmaceuticals
9.12 Zafgen

10 NON ALCOHOLIC FATTY LIVER DISEASE MAUFACTURING COST ANALYSIS

10.1 Non Alcoholic Fatty Liver Disease Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Non Alcoholic Fatty Liver Disease
10.3 Manufacturing Process Analysis of Non Alcoholic Fatty Liver Disease

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Non Alcoholic Fatty Liver Disease Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non Alcoholic Fatty Liver Disease Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL NON ALCOHOLIC FATTY LIVER DISEASE MARKET FORECAST (2017-2022)

14.1 Global Non Alcoholic Fatty Liver Disease Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Non Alcoholic Fatty Liver Disease Price and Trend Forecast (2017-2022)
14.2 Global Non Alcoholic Fatty Liver Disease Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Non Alcoholic Fatty Liver Disease Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Non Alcoholic Fatty Liver Disease Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Non Alcoholic Fatty Liver Disease Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Non Alcoholic Fatty Liver Disease Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Non Alcoholic Fatty Liver Disease Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Non Alcoholic Fatty Liver Disease Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Non Alcoholic Fatty Liver Disease Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Non Alcoholic Fatty Liver Disease Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non Alcoholic Fatty Liver Disease
Table Classification of Non Alcoholic Fatty Liver Disease
Figure Global Sales Market Share of Non Alcoholic Fatty Liver Disease by Type in 2015
Figure Insulin Sensitizers Picture
Figure Statins Picture
Figure Pentoxifylline Picture
Figure Others Picture
Table Applications of Non Alcoholic Fatty Liver Disease
Figure Global Sales Market Share of Non Alcoholic Fatty Liver Disease by Application in 2015
Figure Pediatric? Examples
Figure Adults Examples
Figure United States Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)
Figure China Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)
Figure Europe Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)
Figure Japan Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)
Figure India Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)
Figure Global Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2022)
Figure Global Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2022)
Table Global Non Alcoholic Fatty Liver Disease Sales of Key Manufacturers (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Sales Share by Manufacturers (2012-2017)
Figure 2015 Non Alcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Non Alcoholic Fatty Liver Disease Sales Share by Manufacturers
Table Global Non Alcoholic Fatty Liver Disease Revenue by Manufacturers (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 Global Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table Global Non Alcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Sales Share by Type (2012-2017)
Figure Sales Market Share of Non Alcoholic Fatty Liver Disease by Type (2012-2017)
Figure Global Non Alcoholic Fatty Liver Disease Sales Growth Rate by Type (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non Alcoholic Fatty Liver Disease by Type (2012-2017)
Figure Global Non Alcoholic Fatty Liver Disease Revenue Growth Rate by Type (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Sales and Market Share by Regions (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Sales Share by Regions (2012-2017)
Figure Sales Market Share of Non Alcoholic Fatty Liver Disease by Regions (2012-2017)
Figure Global Non Alcoholic Fatty Liver Disease Sales Growth Rate by Regions (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Revenue and Market Share by Regions (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Non Alcoholic Fatty Liver Disease by Regions (2012-2017)
Figure Global Non Alcoholic Fatty Liver Disease Revenue Growth Rate by Regions (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Sales and Market Share by Application (2012-2017)
Table Global Non Alcoholic Fatty Liver Disease Sales Share by Application (2012-2017)
Figure Sales Market Share of Non Alcoholic Fatty Liver Disease by Application (2012-2017)
Figure Global Non Alcoholic Fatty Liver Disease Sales Growth Rate by Application (2012-2017)
Figure United States Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure United States Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure United States Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table United States Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table United States Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table United States Non Alcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table United States Non Alcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table United States Non Alcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table United States Non Alcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure China Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure China Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure China Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure Europe Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Europe Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Europe Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Europe Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table Europe Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table Europe Non Alcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table Europe Non Alcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table Europe Non Alcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table Europe Non Alcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure Japan Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Japan Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Japan Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Japan Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table Japan Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table Japan Non Alcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table Japan Non Alcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table Japan Non Alcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table Japan Non Alcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure Southeast Asia Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Southeast Asia Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Southeast Asia Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table Southeast Asia Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table Southeast Asia Non Alcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table Southeast Asia Non Alcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table Southeast Asia Non Alcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table Southeast Asia Non Alcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Figure India Non Alcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure India Non Alcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure India Non Alcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table India Non Alcoholic Fatty Liver Disease Sales by Manufacturers (2012-2017)
Table India Non Alcoholic Fatty Liver Disease Market Share by Manufacturers (2012-2017)
Table India Non Alcoholic Fatty Liver Disease Sales by Type (2012-2017)
Table India Non Alcoholic Fatty Liver Disease Market Share by Type (2012-2017)
Table India Non Alcoholic Fatty Liver Disease Sales by Application (2012-2017)
Table India Non Alcoholic Fatty Liver Disease Market Share by Application (2012-2017)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Non Alcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Tobira Therapeutics Non Alcoholic Fatty Liver Disease Global Market Share (2012-2017)
Table Verva Pharmaceuticals Basic Information List
Table Zafgen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non Alcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Non Alcoholic Fatty Liver Disease
Figure Non Alcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Non Alcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Non Alcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure Global Non Alcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2022)
Figure Global Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)
Table Global Non Alcoholic Fatty Liver Disease Sales Forecast by Regions (2017-2022)
Table Global Non Alcoholic Fatty Liver Disease Sales Forecast by Type (2017-2022)
Table Global Non Alcoholic Fatty Liver Disease Sales Forecast by Application (2017-2022)